DCGI tells States to ensure other drug manufacturers do not buy raw materials from Marion Biotech’s supplier; 22 out of 33 samples of the firm’s cough syrup were found to be adulterated or spurious
DCGI tells States to ensure other drug manufacturers do not buy raw materials from Marion Biotech’s supplier; 22 out of 33 samples of the firm’s cough syrup were found to be adulterated or spurious
